Full day, live learning opportunity. Register
29 June 2026 @ Jumar Bioincubator, 655 Elizabeth St, Melbourne
Moving from R&D into regulated non-clinical safety testing is one of the most critical transitions in drug development. Whether your studies are run in-house or through an external lab, your team needs to understand GLP — not just follow it. This full-day, hands-on course uses real case studies, small group workshops, and an expert trainer panel to build the knowledge that protects your data and your development timeline.
This short course is designed for companies conducting pre-clinical laboratory studies. It equips teams with the knowledge to build and manage a compliant quality system — ensuring studies and documentation meet the requirements of relevant GLP principles and regulations. Participants leave with a clear understanding of the compliance framework they need to operate within, helping them avoid gaps, minimise rework, and set their programs up for success.
Includes theory, workshops and assessment
CBEs course on GLPs for Non-clinical Studies is aimed at:
- Early-stage biotech and pharmaceutical companies preparing for first in human programs
What the short course covers:
This course builds foundational knowledge in Good Laboratory Practice for non-clinical studies, covering the requirements of both OECD Principles of GLP and US FDA CFR Part 58. Participants will gain a clear understanding of GLP study structure — including roles, responsibilities, and how early-stage companies can effectively support non-clinical studies. The course addresses sponsor obligations for outsourced activities, GLP-compliant documentation, and test item characterisation, while equipping teams with a science- and risk-based approach to developing analytical test procedures, method verification, assay robustness, and data traceability.
Upon successful completion, students will receive a certificate and credly digital credential.
Contact us: gmpuplift@cbe-ap.com.au